EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt

Zoe Pasvanis, Roy C K Kong, Elsa C Chan, Jennifer C Fan Gaskin iD

Clinical & Experimental Ophthalmology · 2025

DOI: 10.1111/ceo.14578 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2025. Verfasst von Zoe Pasvanis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Flavonols, Filtering Surgery, Cicatrix, Conjunctiva. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: BrightFocus Foundation, University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship, Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The success of minimally invasive bleb surgery (MIBS) such as the PreserFlo MicroShunt (PFMS) is limited by post‐operative bleb fibrosis. Current clinical practice prescribes the use of off‐label cytotoxic antimetabolites such as Mitomycin C (MMC) as antifibrotic therapy. This study investigates the anti‐scarring properties of a novel compound, 3′,4′‐Dihydroxyflavonol (DiOHF) in a rabbit model of PFMS filtration surgery.

Methods

Fifteen New Zealand white rabbits underwent unilateral MIBS with PFMS. Treatment was randomised to the following groups: (1) vehicle ( n = 5), (2) DiOHF ( n = 5), both applied three times daily for 2 weeks or (3) a single dose of MMC administered intraoperatively ( n = 5). Blebs were photographed post‐operatively on Days 0, 7 and 14 for clinical examination. Eyes were harvested on Day 14 and processed for immunohistochemical tissue staining to assess collagen deposition, expression of αSMA, oxidative stress, fibroblast activity, angiogenesis and inflammation in the conjunctiva/Tenon's layer.

Results

At 2‐weeks post‐surgery, MMC blebs were larger and more ischaemic than other treatments (Bleb size: MMC vs. DiOHF, p = 0.0098; MMC vs. vehicle, p = 0.0001. Ischaemia: p = 0.0004 for both). Compared to vehicle control, DiOHF blebs expressed decreased vimentin ( p = 0.0099), αSMA ( p = 0.0231) and 3‐nitrotyrosine ( p = 0.0410) after 2 weeks. DiOHF blebs expressed less CD45 than other treatments (DiOHF vs. Vehicle, p = 0.0013; DiOHF vs. MMC, p = 0.0232) and less collagen accumulation (DiOHF vs. vehicle, p = 0.0512). There was no difference in CD31 expression between treatment groups.

Conclusions

DiOHF inhibited scarring following implantation of PFMS in rabbit eyes by reducing local oxidative stress, inflammation and fibroblastic activity. DiOHF may be a safer and more effective wound modulating agent than the conventional use of MMC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonolsFiltering SurgeryCicatrixConjunctivaAnimalsRabbitsDisease Models, AnimalMinimally Invasive Surgical ProceduresFibrosisCollagenOxidative StressActinsWound Healing

Stichwörter der Autor:innen

fibroblastsglaucomainflammationminimally invasive glaucoma surgeryoxidative stresswound healing

Substanzen

FlavonolsCollagenActins

Autor:innen und Institutionen

  • Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.
  • Ophthalmology, Department of Surgery, University of Melbourne, Parkville, Victoria, Australia.
  • Department of Medicine, St. Vincent's Hospital, University of Melbourne, Parkville, Victoria, Australia.
  • Glaucoma Research and Investigation Unit, Royal Victorian Eye and Ear Hospital, East Melbourne, Victoria, Australia.

ORCID-Profile: Jennifer C Fan Gaskin

Förderung

  • BrightFocus Foundation
  • University of Melbourne Annemarie Mankiewicz-Zelkin Fellowship
  • Victorian State Government's Department of Innovation, Industry and Regional Development's Operational Infrastructure Support Program
  • Australian Government Research Training Program (RTP) Scholarship

Zitieren

APA

Pasvanis, Z., Kong, R. C. K., Chan, E. C., & Fan Gaskin, J. C. (2025). Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14578

Vancouver

Pasvanis Z, Kong RCK, Chan EC, Fan Gaskin JC. Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt. Clinical & Experimental Ophthalmology. 2025. doi:10.1111/ceo.14578

BibTeX
@article{Pasvanis2025,
  author = {Pasvanis, Zoe and Kong, Roy C K and Chan, Elsa C and Fan Gaskin, Jennifer C},
  title = {Inhibitory Effects of 3′,4′‐Dihydroxyflavonol in a Rabbit Model of Minimally Invasive Bleb Surgery With PreserFlo MicroShunt},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2025},
  doi = {10.1111/ceo.14578}
}
Kostenlos starten →